Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$3.82 USD
+0.19 (5.23%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $3.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HCAT 3.82 +0.19(5.23%)
Will HCAT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HCAT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCAT
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
HCAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
Health Catalyst (HCAT) Upgraded to Buy: Here's Why
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for HCAT
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on ...
Health Catalyst (HCAT): Evercore ISI Group Updates Price Target | HCAT Stock News
Deep Dive Into Health Catalyst Stock: Analyst Perspectives (5 Ratings)
Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the ...
Health Catalyst (HCAT) Faces Downgrade Amid Financial Pressures | HCAT Stock News